ScreenerHero

NANOFH Nanoform Finland Oyj

HEL · FI · Healthcare · Biotechnology · nanoform.com
0.7700EUR-3.75%Mkt Cap: 71.77M $P/E: —

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap71.77M USD
Enterprise Value60.80M USD
Revenue (TTM)6.01M USD
Gross Profit3.31M USD
Net Income (TTM)-19.45M USD
Revenue/Share0.06 EUR
Last Price0.7700 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees108
CountryFI
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972
Valuation
P/E (Trailing)—
P/E (Forward)-7.27
PEG—
EV/EBITDA-3.83
EV/Revenue10.12
P/S12.41
P/B1.89
EPS (TTM)-0.16
EPS (Forward)-0.11
52W Range
0.377039% of range1.382
52W High1.382 EUR
52W Low0.3770 EUR
Profitability
Gross Margin85.82%
Oper. Margin-477.29%
EBITDA Margin-264.53%
Profit Margin-504.74%
ROE-41.84%
ROA-33.16%
Growth
Revenue Growth16.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.20M USD
CapEx (TTM)1.24M USD
FCF Margin-140.16%
FCF Yield-11.73%
Net Debt-13.70M USD
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.15
Current Ratio3.12
Quick Ratio2.93
Book Value/Sh0.42 EUR
Cash/Share0.22 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.125 EUR
Upside (mean)+176.0%
Target Range2.000 EUR – 2.250 EUR
2.000+176.0% to mean2.250
# Analysts2
Ownership
Shares Out.85.75M
Float24.67M
Insiders23.28%
Institutions33.96%
Technical
SMA 500.9272 (-17.0%)
SMA 2000.8258 (-6.8%)
Beta0.88
S&P 52W Chg16.45%
Avg Vol (30d)58.93K
Avg Vol (10d)54.48K
Technical Indicators
RSI (14)33.1
MACD-0.0310
MACD Signal-0.0204
MACD Hist.-0.0106
BB Upper0.9647 EUR
BB Middle0.8724 EUR
BB Lower0.7801 EUR
BB Width21.16%
ATR (14)0.0429 EUR
Vol Ratio (20d)1.27x